Prevalence of Anti SARS CoV 2 Antibody in COVID 19 Patients in Japan
T. Konishi. International Journal of Trend in Scientific Research and Development, 5 (3):
375-376(April 2021)
Abstract
The continued spread of coronavirus disease 2019 COVID 19 has prompted widespread concern around the world, and the World Health Organization WHO , on 11 March 2020, declared COVID 19 a pandemic. The significance of performing an antibody test against SARS CoV 2 using serum is to identify asymptomatic SARS CoV 2 infected individuals. Our research group has been studying the prevalence of anti severe acute respiratory syndrome coronavirus 2 SARS CoV 2 antibodies in SARS CoV 2 infected Japanese individuals. Within 20 days after symptom onset, 100 of patients tested positive for antiviral immunoglobulin G IgG . Seroconversion for IgG and IgM occurred simultaneously or sequentially. Both IgG and IgM titers plateaued within 6 days after seroconversion. Takuma Hayashi | Ikuo Konishi "Prevalence of Anti-SARS-CoV-2 Antibody in COVID-19 Patients in Japan" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-3 , April 2021, URL: https://www.ijtsrd.com/papers/ijtsrd39857.pdf Paper URL: https://www.ijtsrd.com/medicine/other/39857/prevalence-of-antisarscov2-antibody-in-covid19-patients-in-japan/takuma-hayashi
%0 Journal Article
%1 noauthororeditor
%A Konishi, Takuma Hayashi | Ikuo
%D 2021
%J International Journal of Trend in Scientific Research and Development
%K COVID-19 IgG IgM SARS-CoV-2 anti-SARS-CoV-2 antibody
%N 3
%P 375-376
%T Prevalence of Anti SARS CoV 2 Antibody in COVID 19 Patients in Japan
%U https://www.ijtsrd.com/medicine/other/39857/prevalence-of-antisarscov2-antibody-in-covid19-patients-in-japan/takuma-hayashi
%V 5
%X The continued spread of coronavirus disease 2019 COVID 19 has prompted widespread concern around the world, and the World Health Organization WHO , on 11 March 2020, declared COVID 19 a pandemic. The significance of performing an antibody test against SARS CoV 2 using serum is to identify asymptomatic SARS CoV 2 infected individuals. Our research group has been studying the prevalence of anti severe acute respiratory syndrome coronavirus 2 SARS CoV 2 antibodies in SARS CoV 2 infected Japanese individuals. Within 20 days after symptom onset, 100 of patients tested positive for antiviral immunoglobulin G IgG . Seroconversion for IgG and IgM occurred simultaneously or sequentially. Both IgG and IgM titers plateaued within 6 days after seroconversion. Takuma Hayashi | Ikuo Konishi "Prevalence of Anti-SARS-CoV-2 Antibody in COVID-19 Patients in Japan" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-3 , April 2021, URL: https://www.ijtsrd.com/papers/ijtsrd39857.pdf Paper URL: https://www.ijtsrd.com/medicine/other/39857/prevalence-of-antisarscov2-antibody-in-covid19-patients-in-japan/takuma-hayashi
@article{noauthororeditor,
abstract = {The continued spread of coronavirus disease 2019 COVID 19 has prompted widespread concern around the world, and the World Health Organization WHO , on 11 March 2020, declared COVID 19 a pandemic. The significance of performing an antibody test against SARS CoV 2 using serum is to identify asymptomatic SARS CoV 2 infected individuals. Our research group has been studying the prevalence of anti severe acute respiratory syndrome coronavirus 2 SARS CoV 2 antibodies in SARS CoV 2 infected Japanese individuals. Within 20 days after symptom onset, 100 of patients tested positive for antiviral immunoglobulin G IgG . Seroconversion for IgG and IgM occurred simultaneously or sequentially. Both IgG and IgM titers plateaued within 6 days after seroconversion. Takuma Hayashi | Ikuo Konishi "Prevalence of Anti-SARS-CoV-2 Antibody in COVID-19 Patients in Japan" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-3 , April 2021, URL: https://www.ijtsrd.com/papers/ijtsrd39857.pdf Paper URL: https://www.ijtsrd.com/medicine/other/39857/prevalence-of-antisarscov2-antibody-in-covid19-patients-in-japan/takuma-hayashi
},
added-at = {2021-06-05T09:15:14.000+0200},
author = {Konishi, Takuma Hayashi | Ikuo},
biburl = {https://www.bibsonomy.org/bibtex/2c91f0cf86889b4fd4cba8d98ec6c9b4f/ijtsrd},
interhash = {ee7c0c67e7bb9d0434703d5003356bf8},
intrahash = {c91f0cf86889b4fd4cba8d98ec6c9b4f},
issn = {2456-6470},
journal = {International Journal of Trend in Scientific Research and Development},
keywords = {COVID-19 IgG IgM SARS-CoV-2 anti-SARS-CoV-2 antibody},
language = {English},
month = {April},
number = 3,
pages = {375-376},
timestamp = {2021-06-05T09:15:14.000+0200},
title = {Prevalence of Anti SARS CoV 2 Antibody in COVID 19 Patients in Japan
},
url = {https://www.ijtsrd.com/medicine/other/39857/prevalence-of-antisarscov2-antibody-in-covid19-patients-in-japan/takuma-hayashi},
volume = 5,
year = 2021
}